Lv1
44 积分 2024-04-26 加入
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
27天前
已完结
Hepatic glycogenesis antagonizes lipogenesis by blocking S1P via UDPG
29天前
已完结
Gut microbiota-derived metabolites as key actors in inflammatory bowel disease
2个月前
已完结
Neutrophils: from IBD to the gut microbiota
3个月前
已完结
ClickRNA-PROTAC for Tumor-Selective Protein Degradation and Targeted Cancer Therapy
4个月前
已完结
A Dual-Target and Dual-Mechanism Design Strategy by Combining Inhibition and Degradation Together
4个月前
已完结
A Dual-Target and Dual-Mechanism Design Strategy by Combining Inhibition and Degradation Together
4个月前
已完结
Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease
7个月前
已完结
Target fishing and mechanistic insights of the natural anticancer drug candidate chlorogenic acid
8个月前
已完结
Bruceine A protects against diabetic kidney disease via inhibiting galectin-1
9个月前
已完结
皖公网安备34019202002308
